Enhancing hepatitis C testing and treatment among people who inject drugs attending needle and syringe programs: the TEMPO Study

加强参加针头和注射器项目的注射吸毒者的丙型肝炎检测和治疗：TEMPO 研究

• 批准号: nhmrc : GNT1169626
• 金额: $ 139.64万
• 依托单位国家: 澳大利亚
• 项目类别: Partnerships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/enhancing-hepatitis-c-tempo-study/1379521
• 关键词: Enhancing; hepatitis; testing; treatment; among

In Australia, 170,000 people are living with hepatitis C, with the majority having a history of injecting drug use (80%) or recent injecting drug use (20%). Reducing the hepatitis C burden requires enhanced hepatitis C testing and treatment for people who inject drugs. This Partnership Project will evaluate an intervention to enhance hepatitis C testing and treatment in needle and syringe programs and develop a translational framework for establishing hepatitis C care in this setting nationally.

在澳大利亚，有17万人患有丙型肝炎，其中大多数人有注射吸毒史（80%）或最近注射吸毒史（20%）。减少丙型肝炎负担需要加强对注射吸毒者的丙型肝炎检测和治疗。该合作项目将评估一项干预措施，以加强针头和注射器项目中的丙型肝炎检测和治疗，并制定一个在全国范围内建立丙型肝炎护理的转化框架。